Advanced search
Publication Cover
Leukemia & Lymphoma Volume 50, 2009 - Issue 10
Submit an article Journal homepage
74
Views
16
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Protein kinase C-beta II expression in diffuse large B-cell lymphoma predicts for inferior outcome of anthracycline-based chemotherapy with and without rituximab

Kritika Chaiwatanatorn Department of Haematology, St. Vincent's Hospital, Melbourne, Australia; Department of Medicine, St. Vincent's Hospital, Melbourne, AustraliaCorrespondence[email protected]
,
Georgia Stamaratis Department of Anatomical Pathology, St. Vincent's Hospital, Melbourne, Australia
,
Ken Opeskin Department of Anatomical Pathology, St. Vincent's Hospital, Melbourne, Australia
,
Frank Firkin Department of Haematology, St. Vincent's Hospital, Melbourne, Australia; Department of Medicine, St. Vincent's Hospital, Melbourne, Australia
&
Harshal Nandurkar Department of Haematology, St. Vincent's Hospital, Melbourne, Australia; Department of Medicine, St. Vincent's Hospital, Melbourne, Australia
Pages 1666-1675 | Received 17 Mar 2009, Accepted 06 Jun 2009, Published online: 08 Oct 2009

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

John D. Hainsworth, Edward R. Arrowsmith, Michael McCleod, Eric D. Hsi, Oday Hamid, Peipei Shi, Boris K. Lin & Luis E. Fayad. (2016) A randomized, phase 2 study of R-CHOP plus enzastaurin vs R-CHOP in patients with intermediate- or high-risk diffuse large B-cell lymphoma. Leukemia & Lymphoma 57:1, pages 216-218.
Read now
Stefania Nobili, Cristina Napoli, Benedetta Puccini, Ida Landini, Gabriele Perrone, Marco Brugia, Gemma Benelli, Morena Doria, Maurizio Martelli, Erica Finolezzi, Alice Di Rocco, Emanuele Del Fava, Luigi Rigacci, Simonetta Di Lollo, Alberto Bosi & Enrico Mini. (2014) Identification of pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B-cell lymphoma. Leukemia & Lymphoma 55:9, pages 2071-2078.
Read now
Rita Coutinho & John Gribben. (2013) Biomarkers of diffuse large B-cell lymphoma: impact on diagnosis, treatment, and prognosis. Current Biomarker Findings 3, pages 17-34.
Read now
Loic Ysebaert & Franck Morschhauser. (2011) Enzastaurin hydrochloride for lymphoma: reassessing the results of clinical trials in light of recent advances in the biology of B-cell malignancies. Expert Opinion on Investigational Drugs 20:8, pages 1167-1174.
Read now

Articles from other publishers (12)

Takahito Kawano, Junichi Inokuchi, Masatoshi Eto, Masaharu Murata & Jeong-Hun Kang. (2022) Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer. Cancers 14:21, pages 5425.
Crossref
Peter MartinNancy L. Bartlett, Julio C. ChavezJohn L. ReaganSonali M. Smith, Ann S. LaCasce, Jeffrey Jones, James Drew, Chengqing Wu, Erin MulveyMaria V. Revuelta, Leandro Cerchietti & John P. Leonard. (2022) Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCL. Blood 139:8, pages 1147-1159.
Crossref
Xiaohong Mary Zhang & Yi Ding. 2022. Handbook of Practical Immunohistochemistry. Handbook of Practical Immunohistochemistry 751 798 .
Brian G. Till. (2018) Maintenance Therapy in Diffuse Large B Cell Lymphoma and Mantle Cell Lymphoma. Current Treatment Options in Oncology 19:9.
Crossref
Rosalba Camicia, Hans C. Winkler & Paul O. Hassa. (2015) Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review. Molecular Cancer 14:1.
Crossref
Fritz OffnerOlga SamoilovaEvgenii OsmanovHyeon-Seok EomMax S. ToppJoão RaposoViacheslav PavlovDeborah RicciShalini ChaturvediEugene ZhuHelgi van de Velde, Christopher EnnyAleksandra RizoBurhan Ferhanoglu. (2015) Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL. Blood 126:16, pages 1893-1901.
Crossref
Daniela Brina, Annarita Miluzio, Sara Ricciardi & Stefano Biffo. (2015) eIF6 anti-association activity is required for ribosome biogenesis, translational control and tumor progression. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1849:7, pages 830-835.
Crossref
Xiaohong Zhang & Nadine S. Aguilera. 2015. Handbook of Practical Immunohistochemistry. Handbook of Practical Immunohistochemistry 591 628 .
Alexandra Schrader, Katharina Meyer, Frederike von Bonin, Martina Vockerodt, Neele Walther, Elisabeth Hand, Antje Ulrich, Kamila Matulewicz, Dido Lenze, Michael Hummel, Arnd Kieser, Michael Engelke, Lorenz Trümper & Dieter Kube. (2012) Global gene expression changes of in vitro stimulated human transformed germinal centre B cells as surrogate for oncogenic pathway activation in individual aggressive B cell lymphomas. Cell Communication and Signaling 10:1, pages 43.
Crossref
Annarita Miluzio, Anne Beugnet, Stefano Grosso, Daniela Brina, Marilena Mancino, Stefano Campaner, Bruno Amati, Ario de Marco & Stefano Biffo. (2011) Impairment of Cytoplasmic eIF6 Activity Restricts Lymphomagenesis and Tumor Progression without Affecting Normal Growth. Cancer Cell 19:6, pages 765-775.
Crossref
Xiaohong Zhang & Nadine S. Aguilera. 2011. Handbook of Practical Immunohistochemistry. Handbook of Practical Immunohistochemistry 461 491 .
Michele Roullet & Adam Bagg. (2010) The Basis and Rational Use of Molecular Genetic Testing in Mature B-cell Lymphomas. Advances in Anatomic Pathology 17:5, pages 333-358.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.